Press Releases Bastide Le Confort Médical London S.E.

Equities

0IP1

FR0000035370

Delayed London S.E. Other stock markets 11:30:39 2024-04-16 EDT			5-day change	1st Jan Change
15.62 ^EUR	-54.92%		-17.17%	-41.49%

05-15	BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction
05-15	Bastide: 8.2% increase in quarterly sales	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bastide Le Confort Médical : Organic growth accelerated in third quarter 2023-2024 up 7.5% and sale of Homecare business in Switzerland in progress	05-15	AT
2024.05.15 Organic growth accelerated in third quarter 2023 2024: up 7.5% Sale of Homecare business in Switzerland in progress 2023 2024 targets adjusted from scope effect confirmed	05-15	PU
Bastide Le Confort Médical : Respiratory care therapy: Bastide wins new United Kingdom region - EUR 10 million/year contract for a minimum of seven years	04-08	AT
Bastide Le Confort Médical : 2023-2024 half-yearly results : Organic growth up 5.7%, EBITDA up 7.5%, Increase in recurring operating profit despite the inflationary context and margin of 8.3%. 2023-2024 outlook confirmed	03-20	AT
Bastide Le Confort Médical : Organic growth accelerated to 6.1% in second-quarter 2023-2024 and confirmation of 2023-2024 adjusted targets	02-15	AT
Bastide Le Confort Médical : Strategic sale of e-commerce subsidiary Distrimed	12-04	AT
Bastide Le Confort Médical : Dynamic 7% growth in first-quarter 2023-2024 / 2023-2024 targets confirmed	11-16	AT
Bastide Le Confort Médical : Groupe Bastide announces its 2023-2024 financial calendar	23-10-19	AT
Bastide Le Confort Médical : 2022-2023 annual results: Record EBITDA of over EUR 100 million, Recurring operating margin of 8.4%, exceeding the target, Operating free cash flow of EUR 39 million // 2023-2024 outlook: sustained growth and a focus on reducing debt	23-10-18	AT
Bastide Le Confort Médical : Annual revenue of EUR 508 million, growth of 11.0%, in line with the target // 2022-2023 profitability targets confirmed	23-08-30	AT
Bastide Le Confort Médical : Groupe Bastide strengthens its position in home healthcare services in France and expands into the Netherlands	23-07-06	AT
Bastide Le Confort Médical : Changes in Group’s Executive Management following the departure of Jean-Claude Brdenk	23-06-30	AT
Bastide Le Confort Médical : BASTIDE : Organic growth accelerated to 9.1% in third-quarter 2022-2023 // 2022-2023 targets confirmed	23-05-10	AT
Bastide Le Confort Médical : BASTIDE - 2022-2023 half-year results _ Increase in operating FCF and outlook confirmed	23-03-22	AT
Bastide Le Confort Médical : BASTIDE : Sustained 14.1% growth in first-half 2022-2023	23-02-15	AT
Bastide Le Confort Médical : Dynamic 12.8% growth in Q1 2022 2023	22-11-16	AT
Bastide Le Confort Médical : BASTIDE : 2021-2022 annual results	22-10-18	AT
Bastide Le Confort Médical : Annual revenue of EUR468 million up 5.4% exceeding the annual target / Organic growth resumes in Q4: up 6.1%	22-08-31	AT
Bastide Le Confort Médical : The Bastide Group enters the respiratory care devices market in Italy	22-07-18	AT
Bastide Le Confort Médical : Acceleration in growth in the third quarter, to 6% - Outlook confirmed	22-05-12	AT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction

May 15, 2024 at 02:40 pm